Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

14
How Do You Follow Sergio Marchionne - Bloomberg

2018-07-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
VLKAF GM.WS.A GM.WS.B GM.WS.C GM GM.WSB

18
Automakers Oppose Tariffs: Will Trump Administration Yield?

2018-07-20 zacks
Auto groups and foreign governments vehemently opposed the idea of tariffs on imported cars at a hearing held by the Commerce Department on Jul 19. President Donald Trump’s plans of imposing tariffs on imported cars haven’t gone down well with automakers, who feel it will hurt the U.S economy.
TM TYT DDAIF HOG TOYOF VLKAF GM.WS.A GM.WS.B GM.WS.C 7203 GM FCAU GM.WSB VLKAY

14
Factbox: Impact of trade tariffs on European companies

2018-07-20 reuters
(Reuters) - Some European companies are rethinking their strategies to cushion against the impact of trade tensions between the world’s two biggest economies, the United States and China.
VLKAF GM.WS.A TM GM.WS.B GM.WS.C 7203 TYT GM GM.WSB TOYOF

14
EU, Mexico automakers blast Trump auto tariff plan

2018-07-20 malaymail
WASHINGTON, July 20 ― The Trump administration yesterday came under withering criticism from automakers, foreign governments and others as officials consider imposing tariffs of up to 25 per cent on imported cars and parts, a levy that could hike vehicle costs, hurting auto sales and industry jobs.
VLKAF GM.WS.A TM GM.WS.B GM.WS.C 7203 TYT GM GM.WSB TOYOF

0
Volkswagen to furlough 1,000 workers in Brazil as sales slow -union

2018-07-19 reuters
SAO PAULO (Reuters) - Volkswagen AG (VOWG_p.DE) will furlough about 1,000 workers at its largest factory in Brazil, union representatives said on Thursday, due to weaker economic growth and slumping exports to Argentina.
VLKAF

0
German Car Giants Get Cold Comfort From EU Competition Commissioner Ahead of Tariffs - Bloomberg

2018-07-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
VLKAF DDAIF

0
VW CEO Diess pushes for margin improvements: Manager Magazin

2018-07-19 channelnewsasia
Volkswagen Group's new chief executive Herbert Diess is pushing for faster margin improvements at its main Porsche, Audi and VW brands, German monthly Manager Magazin said.
VLKAF

0
VW CEO Diess pushes for margin improvements: Manager Magazin

2018-07-19 reuters
FRANKFURT (Reuters) - Volkswagen Group’s (VOWG_p.DE) new chief executive Herbert Diess is pushing for faster margin improvements at its main Porsche, Audi and VW brands, German monthly Manager Magazin said.
VLKAF

14
UPDATE 1-'Too early' to say if U.S. will impose auto tariffs -Commerce Secretary

2018-07-19 reuters
WASHINGTON (Reuters) - Commerce Secretary Wilbur Ross said Thursday it was “too early” to say if the United States would impose tariffs of up to 25 percent on imported cars and parts, a suggestion that has been met with harsh criticism from the industry.
VLKAF GM.WS.A TM GM.WS.B GM.WS.C 7203 TYT GM GM.WSB TOYOF

14
US tariffs could raise auto prices by US$83b, trade group says

2018-07-18 malaymail
WASHINGTON, July 19 — A group representing major automakers will tell the US Commerce Department today that imposing tariffs of 25 per cent on imported cars and parts would raise the price of US vehicles by US$83 billion (RM336.9 billion) annually and cost hundreds of thousands of jobs.
HYUO TM TYT TOYOF HYUD VLKAF GM.WS.A GM.WS.B GM.WS.C 7203 HYUP GM GM.WSB

14
US tariffs could raise vehicle prices by US$83 billion: auto trade group

2018-07-18 channelnewsasia
A group representing major automakers will tell the U.S. Commerce Department on Thursday that imposing tariffs of 25 percent on imported cars and parts would raise the price of U.S. vehicles by US$83 billion annually and would cost hundreds of thousands of jobs.
VLKAF GM.WS.A TM GM.WS.B GM.WS.C 7203 TYT GM GM.WSB TOYOF

14
U.S. tariffs could raise vehicle prices by $83 billion: auto trade group

2018-07-18 reuters
WASHINGTON (Reuters) - A group representing major automakers will tell the U.S. Commerce Department on Thursday that imposing tariffs of 25 percent on imported cars and parts would raise the price of U.S. vehicles by $83 billion annually and would cost hundreds of thousands of jobs.
VLKAF GM.WS.A TM GM.WS.B GM.WS.C 7203 TYT GM GM.WSB TOYOF

0
EU electric-car sale growth sputters on battery, charging limits

2018-07-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
VLKAF DDAIF

0
Harley, Trump and Thailand’s big trade gamble: Andy Mukherjee

2018-07-17 theedgemarkets
(July 17): Democracies look to voters for validation of their economic policies. For Thailand’s military junta, the affirmation is coming from Beijing, bankers and the likes of Harley-Davidson Inc.
VLKAF KWHIF KWHIY 7012

3
Harley, Trump and Thailand’s $51 Billion Trade Gamble - Bloomberg

2018-07-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
VLKAF KWHIF KWHIY 7012 HOG

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...